Vaxart Stock News

Vaxart Inc. (NASDAQ: VXRT) shares are trading higher Wednesday.  The company announced that an executive will present an overview of the company’s COVID-19 oral vaccine candidate at the World Vacci

Vaxart Inc. (NASDAQ: VXRT ) shares are trading higher Wednesday. The company announced that an executive will present an overview of the companys COVID-19 oral vaccine candidate at the World Vaccine & Immunotherapy Congress on Tuesday, Nov. 30, 2021. The stock is nearing the end of a pattern and could see a push soon. Vaxart was trading 3.31% higher at $7.02 Wednesday afternoon. See Related: Vaxart Stock Is Being Squeezed At The End Of A Pattern Vaxart Daily Chart Analysis Shares are nearing the end of what technical traders call a pennant pattern and may see a breakout of the pattern before the year''s end. The price has been getting condensed between narrowing highs and lows Full story available on Benzinga.com

Vaxart Inc. (NASDAQ:VXRT) shares are trading higher Wednesday.  The company announced that an executive will present an overview of the company's COVID-19 oral vaccine candidate at the World Vaccine

Amalgamated Bank purchased a new stake in Vaxart, Inc. (NASDAQ:VXRT) in the second quarter, according to its most recent filing with the SEC. The fund purchased 22,035 shares of the biotechnology companys stock, valued at approximately $165,000. Other hedge funds and other institutional investors have also recently modified their holdings of the company. BlackRock Inc. []

SOUTH SAN FRANCISCO, Calif., Nov. 23, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced that Dr. Sean Tucker, SVP and Chief Scientific Officer, will present at the World Vaccine & Immunotherapy Congress West Coast 2021 in San Diego on Tuesday, November 30, 2021 at 2:40 p.m. PT.

California State Teachers Retirement System increased its position in shares of Vaxart, Inc. (NASDAQ:VXRT) by 108.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 164,808 shares of the biotechnology company’s stock after acquiring an additional 85,801 shares during […]

Nuveen Asset Management LLC grew its holdings in shares of Vaxart, Inc. (NASDAQ:VXRT) by 111.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 423,039 shares of the biotechnology companys stock after purchasing an additional 222,868 shares during the quarter. Nuveen Asset Management LLC []

Brokerages expect Vaxart, Inc. (NASDAQ:VXRT) to post $860,000.00 in sales for the current quarter, Zacks Investment Research reports. Four analysts have provided estimates for Vaxarts earnings. The highest sales estimate is $2.70 million and the lowest is $200,000.00. Vaxart reported sales of $360,000.00 in the same quarter last year, which would suggest a positive year-over-year []

Catalysts for the stocks are just ahead.

Catalysts for the stocks are just ahead.

A new Stanford study published in Cell Host and Microbe finds that protection against influenza infection may be achieved through mechanisms other than the development of serum antibodies A new Stanfo

A new Stanford study published in Cell Host and Microbe finds that protection against influenza infection may be achieved through mechanisms other than the development of serum antibodies A new Stanford study published in Cell Host and Microbe finds that protection against influenza infection may be achieved through mechanisms other than the development of serum antibodies

Vaxart Inc. (NASDAQ:VXRT)s traded shares stood at 2.9 million during the latest session, with the companys beta value hitting 0.23. At the last check today, the stocks price was $7.09, to imply an increase of 5.11% or $0.34 in intraday trading. The VXRT shares 52-week high remains $24.90, putting it -251.2% down since that peak Vaxart Inc. At $7.09: Buy, Sell Or Hold? Read More »

NEW YORK, Nov. 18, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, F, XELA, VXRT, and GOEV. To see how InvestorsObserver''s proprietary scoring system rates these stocks, view the InvestorsObserver''s PriceWatch Alert by selecting the corresponding link.